Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1966 1
1967 1
1968 1
1969 3
1971 1
1972 1
1973 2
1974 2
1976 1
1985 1
1987 1
1988 3
1989 4
1990 2
1991 4
1992 3
1993 3
1994 6
1995 7
1996 9
1997 3
1998 6
1999 3
2000 4
2001 7
2002 5
2003 8
2004 8
2005 13
2006 14
2007 16
2008 15
2009 16
2010 13
2011 13
2012 15
2013 14
2014 21
2015 24
2016 13
2017 21
2018 22
2019 26
2020 18
2021 26
2022 25
2023 13
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

406 results

Results by year

Filters applied: . Clear all
Page 1
Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: a randomised, phase 1b/2 trial.
Reiss KA, Mick R, Teitelbaum U, O'Hara M, Schneider C, Massa R, Karasic T, Tondon R, Onyiah C, Gosselin MK, Donze A, Domchek SM, Vonderheide RH. Reiss KA, et al. Lancet Oncol. 2022 Aug;23(8):1009-1020. doi: 10.1016/S1470-2045(22)00369-2. Epub 2022 Jul 7. Lancet Oncol. 2022. PMID: 35810751 Free PMC article. Clinical Trial.
Phase II Study of Maintenance Rucaparib in Patients With Platinum-Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or Somatic Variant in BRCA1, BRCA2, or PALB2.
Reiss KA, Mick R, O'Hara MH, Teitelbaum U, Karasic TB, Schneider C, Cowden S, Southwell T, Romeo J, Izgur N, Hannan ZM, Tondon R, Nathanson K, Vonderheide RH, Wattenberg MM, Beatty G, Domchek SM. Reiss KA, et al. J Clin Oncol. 2021 Aug 1;39(22):2497-2505. doi: 10.1200/JCO.21.00003. Epub 2021 May 10. J Clin Oncol. 2021. PMID: 33970687 Clinical Trial.
PARP Inhibitors in Pancreatic Cancer.
Brown TJ, Reiss KA. Brown TJ, et al. Among authors: reiss ka. Cancer J. 2021 Nov-Dec 01;27(6):465-475. doi: 10.1097/PPO.0000000000000554. Cancer J. 2021. PMID: 34904809 Free PMC article. Review.
Double Labeling Fluorescent Immunocytochemistry.
Rak M, Reiss K. Rak M, et al. Among authors: reiss k. Methods Mol Biol. 2022;2422:147-161. doi: 10.1007/978-1-0716-1948-3_10. Methods Mol Biol. 2022. PMID: 34859404
Scramblases as Regulators of Proteolytic ADAM Function.
Reiss K, Leitzke S, Seidel J, Sperrhacke M, Bhakdi S. Reiss K, et al. Membranes (Basel). 2022 Feb 4;12(2):185. doi: 10.3390/membranes12020185. Membranes (Basel). 2022. PMID: 35207106 Free PMC article. Review.
Targeting BRCA and PALB2 in Pancreatic Cancer.
Anbil S, Reiss KA. Anbil S, et al. Among authors: reiss ka. Curr Treat Options Oncol. 2024 Mar;25(3):346-363. doi: 10.1007/s11864-023-01174-0. Epub 2024 Jan 4. Curr Treat Options Oncol. 2024. PMID: 38311708 Review.
Healthy, but comatose.
Houston B, Reiss KA, Merlo C. Houston B, et al. Among authors: reiss ka. Am J Med. 2011 Apr;124(4):303-5. doi: 10.1016/j.amjmed.2010.12.002. Am J Med. 2011. PMID: 21435419 No abstract available.
The Clinical Implications of Reversions in Patients with Advanced Pancreatic Cancer and Pathogenic Variants in BRCA1, BRCA2, or PALB2 after Progression on Rucaparib.
Brown TJ, Yablonovitch A, Till JE, Yen J, Kiedrowski LA, Hood R, O'Hara MH, Teitelbaum U, Karasic TB, Schneider C, Carpenter EL, Nathanson K, Domchek SM, Reiss KA. Brown TJ, et al. Among authors: reiss ka. Clin Cancer Res. 2023 Dec 15;29(24):5207-5216. doi: 10.1158/1078-0432.CCR-23-1467. Clin Cancer Res. 2023. PMID: 37486343
Analysis of BRCA1- and BRCA2-Related Pancreatic Cancer and Survival.
Boursi B, Wileyto EP, Mamtani R, Domchek SM, Golan T, Hood R, Reiss KA. Boursi B, et al. Among authors: reiss ka. JAMA Netw Open. 2023 Nov 1;6(11):e2345013. doi: 10.1001/jamanetworkopen.2023.45013. JAMA Netw Open. 2023. PMID: 38010655 Free PMC article.
Nuclear IRS-1 and cancer.
Reiss K, Del Valle L, Lassak A, Trojanek J. Reiss K, et al. J Cell Physiol. 2012 Aug;227(8):2992-3000. doi: 10.1002/jcp.24019. J Cell Physiol. 2012. PMID: 22454254 Free PMC article. Review.
406 results